World Health Organization. WHO Coronavirus (COVID-19) dashboard. Geneva, Switzerland: World Health Organization; 2023. https://covid19.who.int/.

Google Scholar 

Toussi SS, Hammond JL, Gerstenberger BS, Anderson AS. Therapeutics for COVID-19. Nat Microbiol. 2023;8:771–86. https://doi.org/10.1038/s41564-023-01356-4.

Article  CAS  PubMed  Google Scholar 

El-Sadr WM, Vasan A, El-Mohandes A. Facing the new Covid-19 reality. N Engl J Med. 2023;388:385–7. https://doi.org/10.1056/NEJMp2213920.

Article  PubMed  Google Scholar 

Nalbandian A, Desai AD, Wan EY. Post-COVID-19 condition. Annu Rev Med. 2023;74:55–64. https://doi.org/10.1146/annurev-med-043021-030635.

Article  CAS  PubMed  Google Scholar 

Mueller MR, Ganesh R, Hurt RT, Beckman TJ. Post-COVID conditions. Mayo Clin Proc. 2023;98:1071–8. https://doi.org/10.1016/j.mayocp.2023.04.007.

Article  PubMed  Google Scholar 

Centers for Disease Control and Prevention. New ICD-10-CM code for post-COVID conditions, following the 2019 novel coronavirus (COVID-19). 2021. https://www.cdc.gov/nchs/data/icd/announcement-new-icd-code-for-post-covid-condition-april-2022-final.pdf.

Morello R, Mariani F, Mastrantoni L, De Rose C, Zampino G, Munblit D, et al. Risk factors for post-COVID-19 condition (Long Covid) in children: a prospective cohort study. eClinicalMedicine. 2023;59. https://doi.org/10.1016/j.eclinm.2023.101961.

Steenblock C, Schwarz PEH, Ludwig B, Linkermann A, Zimmet P, Kulebyakin K, et al. COVID-19 and metabolic disease: mechanisms and clinical management. Lancet Diabetes Endocrinol. 2021;9:786–98. https://doi.org/10.1016/s2213-8587(21)00244-8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Stefan N. Metabolic disorders, COVID-19 and vaccine-breakthrough infections. Nat Rev Endocrinol. 2022;18:75–6. https://doi.org/10.1038/s41574-021-00608-9.

Article  CAS  PubMed  Google Scholar 

Stefan N, Birkenfeld AL, Schulze MB. Global pandemics interconnected—obesity, impaired metabolic health and COVID-19. Nat Rev Endocrinol. 2021;17:135–49. https://doi.org/10.1038/s41574-020-00462-1.

Article  CAS  PubMed  Google Scholar 

Almuwaqqat Z, Hui Q, Liu C, Zhou JJ, Voight BF, Ho Y-L, et al. Long-term body mass index variability and adverse cardiovascular outcomes. JAMA Netw Open. 2024;7:e243062. https://doi.org/10.1001/jamanetworkopen.2024.3062.

Article  PubMed  PubMed Central  Google Scholar 

Reiterer M, Rajan M, Gómez-Banoy N, Lau JD, Gomez-Escobar LG, Ma L, et al. Hyperglycemia in acute COVID-19 is characterized by insulin resistance and adipose tissue infectivity by SARS-CoV-2. Cell Metab. 2021;33:2174–88.e5. https://doi.org/10.1016/j.cmet.2021.09.009.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Martínez-Colón GJ, Ratnasiri K, Chen H, Jiang S, Zanley E, Rustagi A, et al. SARS-CoV-2 infection drives an inflammatory response in human adipose tissue through infection of adipocytes and macrophages. Sci Transl Med. 2022;14:eabm9151. https://doi.org/10.1126/scitranslmed.abm9151.

Article  CAS  PubMed  Google Scholar 

Luo S, Liang Y, Wong THT, Schooling CM, Au Yeung SL. Identifying factors contributing to increased susceptibility to COVID-19 risk: a systematic review of Mendelian randomization studies. Int J Epidemiol. 2022;51:1088–105. https://doi.org/10.1093/ije/dyac076.

Article  PubMed  Google Scholar 

Tsampasian V, Elghazaly H, Chattopadhyay R, Debski M, Naing TKP, Garg P, et al. Risk factors associated with post−COVID-19 condition: a systematic review and meta-analysis. JAMA Intern Med. 2023;183:566–80. https://doi.org/10.1001/jamainternmed.2023.0750.

Article  PubMed  PubMed Central  Google Scholar 

Peluso MJ, Deeks SG. Early clues regarding the pathogenesis of long-COVID. Trends Immunol. 2022;43:268–70. https://doi.org/10.1016/j.it.2022.02.008.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Russell CD, Lone NI, Baillie JK. Comorbidities, multimorbidity and COVID-19. Nat Med. 2023;29:334–43. https://doi.org/10.1038/s41591-022-02156-9.

Article  CAS  PubMed  Google Scholar 

Lissner L, Odell PM, D’Agostino RB, Stokes J, Kreger BE, Belanger AJ, et al. Variability of body weight and health outcomes in the Framingham population. N Engl J Med. 1991;324:1839–44. https://doi.org/10.1056/nejm199106273242602.

Article  CAS  PubMed  Google Scholar 

Blair SN, Shaten J, Brownell K, Collins G, Lissner L. Body weight change, all-cause mortality, and cause-specific mortality in the multiple risk factor intervention trial. Ann Intern Med. 1993;119:749–57. https://doi.org/10.7326/0003-4819-119-7_part_2-199310011-00024.

Hussain SM, Newman AB, Beilin LJ, Tonkin AM, Woods RL, Neumann JT, et al. Associations of change in body size with all-cause and cause-specific mortality among healthy older adults. JAMA Netw Open. 2023;6:e237482. https://doi.org/10.1001/jamanetworkopen.2023.7482.

Article  PubMed  PubMed Central  Google Scholar 

Dasa O, Smith SM, Howard G, Cooper-DeHoff RM, Gong Y, Handberg E, et al. Association of 1-year blood pressure variability with long-term mortality among adults with coronary artery disease: a post hoc analysis of a randomized clinical trial. JAMA Netw Open. 2021;4:e218418. https://doi.org/10.1001/jamanetworkopen.2021.8418.

Article  PubMed  PubMed Central  Google Scholar 

Wang J, Jin R, Jin X, Wu Z, Zhang H, Han Z, et al. Separate and joint associations of remnant cholesterol accumulation and variability with carotid atherosclerosis: a prospective cohort study. J Am Heart Assoc. 2023;12:e029352. https://doi.org/10.1161/JAHA.122.029352.

Article  PubMed  PubMed Central  Google Scholar 

Stevens SL, Wood S, Koshiaris C, Law K, Glasziou P, Stevens RJ, et al. Blood pressure variability and cardiovascular disease: systematic review and meta-analysis. BMJ. 2016;354:i4098. https://doi.org/10.1136/bmj.i4098.

Article  PubMed  PubMed Central  Google Scholar 

Schutte AE, Kollias A, Stergiou GS. Blood pressure and its variability: classic and novel measurement techniques. Nat Rev Cardiol. 2022;19:643–54. https://doi.org/10.1038/s41569-022-00690-0.

Article  PubMed  PubMed Central  Google Scholar 

Sheikh AB, Sobotka PA, Garg I, Dunn JP, Minhas AMK, Shandhi MMH, et al. Blood pressure variability in clinical practice: past, present and the future. J Am Heart Assoc. 2023;12:e029297. https://doi.org/10.1161/JAHA.122.029297.

Article  PubMed  PubMed Central  Google Scholar 

Clark D III, Nicholls SJ, St John J, Elshazly MB, Ahmed HM, Khraishah H, et al. Visit-to-visit blood pressure variability, coronary atheroma progression, and clinical outcomes. JAMA Cardiol. 2019;4:437–43. https://doi.org/10.1001/jamacardio.2019.0751.

Article  PubMed  PubMed Central  Google Scholar 

Wang H, Sun X, Von Cannon JL, Kon ND, Ferrario CM, Groban L. Estrogen receptors are linked to angiotensin-converting enzyme 2 (ACE2), ADAM metallopeptidase domain 17 (ADAM-17), and transmembrane protease serine 2 (TMPRSS2) expression in the human atrium: insights into COVID-19. Hypertens Res. 2021;44:882–4.https://doi.org/10.1038/s41440-021-00626-0.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Messerli FH, Rimoldi SF, Bangalore S. Blood pressure variability and arterial stiffness—chicken or egg? JAMA Cardiol. 2019;4:1050. https://doi.org/10.1001/jamacardio.2019.2730.

Article  PubMed  Google Scholar 

Wernstedt Asterholm I, Tao C, Morley TS, Wang QA, Delgado-Lopez F, Wang ZV, et al. Adipocyte inflammation is essential for healthy adipose tissue expansion and remodeling. Cell Metab. 2014;20:103–18. https://doi.org/10.1016/j.cmet.2014.05.005.

Article  CAS  PubMed  Google Scholar 

Chavakis T, Alexaki VI, Ferrante AW. Macrophage function in adipose tissue homeostasis and metabolic inflammation. Nat Immunol. 2023;24:757–66. https://doi.org/10.1038/s41590-023-01479-0.

Article  CAS